144 related articles for article (PubMed ID: 3289523)
1. Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms.
Csernansky JG; Riney SJ; Lombrozo L; Overall JE; Hollister LE
Arch Gen Psychiatry; 1988 Jul; 45(7):655-9. PubMed ID: 3289523
[TBL] [Abstract][Full Text] [Related]
2. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
Rickels K; Chung HR; Csanalosi IB; Hurowitz AM; London J; Wiseman K; Kaplan M; Amsterdam JD
Arch Gen Psychiatry; 1987 Oct; 44(10):862-6. PubMed ID: 3310952
[TBL] [Abstract][Full Text] [Related]
3. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
Maletzky BM
J Int Med Res; 1980; 8(2):139-43. PubMed ID: 6102940
[TBL] [Abstract][Full Text] [Related]
5. Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results.
Wolkowitz OM; Breier A; Doran A; Kelsoe J; Lucas P; Paul SM; Pickar D
Arch Gen Psychiatry; 1988 Jul; 45(7):664-71. PubMed ID: 3289524
[TBL] [Abstract][Full Text] [Related]
6. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
Cohn JB
J Clin Psychiatry; 1981 Sep; 42(9):347-51. PubMed ID: 6115853
[TBL] [Abstract][Full Text] [Related]
7. A controlled clinical trial of alprazolam for the treatment of anxiety.
Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H
Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927
[TBL] [Abstract][Full Text] [Related]
8. Alprazolam compared to diazepam and placebo in the treatment of anxiety.
Aden GC; Thein SG
J Clin Psychiatry; 1980 Jul; 41(7):245-8. PubMed ID: 6993446
[TBL] [Abstract][Full Text] [Related]
9. Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia.
Barbee JG; Mancuso DM; Freed CR; Todorov AA
Am J Psychiatry; 1992 Apr; 149(4):506-10. PubMed ID: 1348161
[TBL] [Abstract][Full Text] [Related]
10. Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings.
Adinoff B
Alcohol Clin Exp Res; 1994 Aug; 18(4):873-8. PubMed ID: 7978098
[TBL] [Abstract][Full Text] [Related]
11. A double-blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients.
Davison K; Farquharson RG; Khan MC; Majid A
Br J Clin Pharmacol; 1985; 19 Suppl 1(Suppl 1):37S-43S. PubMed ID: 2859877
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlates.
Douyon R; Angrist B; Peselow E; Cooper T; Rotrosen J
Am J Psychiatry; 1989 Feb; 146(2):231-4. PubMed ID: 2563211
[TBL] [Abstract][Full Text] [Related]
13. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia.
Wolkowitz OM; Pickar D; Doran AR; Breier A; Tarell J; Paul SM
Am J Psychiatry; 1986 Jan; 143(1):85-7. PubMed ID: 2867690
[TBL] [Abstract][Full Text] [Related]
14. Comparison of alprazolam and imipramine for treatment of outpatient depression.
Overall JE; Biggs J; Jacobs M; Holden K
J Clin Psychiatry; 1987 Jan; 48(1):15-9. PubMed ID: 3542981
[TBL] [Abstract][Full Text] [Related]
15. A double blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients.
Davison K; Farquharson RG; Khan MC; Majid A
Psychopharmacology (Berl); 1983; 80(4):308-10. PubMed ID: 6137856
[TBL] [Abstract][Full Text] [Related]
16. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
[TBL] [Abstract][Full Text] [Related]
17. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
[TBL] [Abstract][Full Text] [Related]
18. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
Lydiard RB; Ballenger JC; Rickels K
J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
[TBL] [Abstract][Full Text] [Related]
19. Diazepam versus alprazolam for the treatment of panic disorder.
Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
[TBL] [Abstract][Full Text] [Related]
20. Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol.
Kolin IS; Linet OI
J Clin Psychiatry; 1981 Apr; 42(4):169-73. PubMed ID: 7009593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
